Publication: Pulmonary Mucormycosis secondary to Severe Acute Respiratory Illness due to Covid 19 Infection: A Case Report Authors
| creativeworkseries.issn | ISSN 2822-1893 eISSN 2822-2016 | |
| dc.contributor.author | Karthak, Ashish | |
| dc.contributor.author | Shrestha, Ashish | |
| dc.contributor.author | Gurung, Naresh | |
| dc.contributor.author | Bhusal, Yuvaraj | |
| dc.contributor.author | Lama, Rakesh | |
| dc.contributor.author | Rayamajhi, Sulav | |
| dc.contributor.author | Bhattarai, Sanjeet | |
| dc.contributor.author | Regmi, Asim | |
| dc.contributor.author | Ghimire, Anup | |
| dc.contributor.author | Khanal, Kishor | |
| dc.contributor.author | Shrestha, Sanjeet K | |
| dc.date.accessioned | 2026-02-03T07:08:51Z | |
| dc.date.available | 2026-02-03T07:08:51Z | |
| dc.date.issued | 2022 | |
| dc.description | Ashish Karthak Department of Pulmonary, Critical care and Sleep Medicine, Nepal Mediciti Hospital, Nepal Ashish Shrestha Department of Pulmonary, Critical care and Sleep Medicine, Nepal Mediciti Hospital, Nepal Naresh Gurung Department of Pulmonary, Critical care and Sleep Medicine, Nepal Mediciti Hospital, Nepal Yuvaraj Bhusal Department of Pulmonary, Critical care and Sleep Medicine, Nepal Mediciti Hospital, Nepal Rakesh Lama Department of Pulmonary, Critical care and Sleep Medicine, Nepal Mediciti Hospital, Nepal Sulav Rayamajhi Department of Pulmonary, Critical care and Sleep Medicine, Nepal Mediciti Hospital, Nepal Sanjeet Bhattarai Department of Pulmonary, Critical care and Sleep Medicine, Nepal Mediciti Hospital, Nepal Asim Regmi Department of Critical care Medicine, Nepal Mediciti Hospital, Nepal Anup Ghimire Department of Critical care Medicine, Nepal Mediciti Hospital, Nepal Kishor Khanal Department of Critical care Medicine, Nepal Mediciti Hospital, Nepal Sanjeet K Shrestha Department of Pulmonary, Critical care and Sleep Medicine, Nepal Mediciti Hospital, Nepal | |
| dc.description.abstract | Abstract: Patients diagnosed and hospitalized with SARS COV-2 are managed with corticosteroids due to its known benefits for the prevention of airway inflammation secondary to acute respiratory distress syndrome seen commonly in viral pneumonia. However, these patients carry a high risk of developing secondary bacterial and fungal infection. We present a case of 60-year-old male with COVID-19 pneumonia. The patient was diagnosed with pulmonary mucormycosis 18 days following admission. The patient was treated with broad-spectrum antibiotics, remdesivir and corticosteroids along with antifungals including voriconazole and amphotericin B with no significant improvement. However, even after extensive medical management patient was eventually intubated and succumbed to its complications. Mucormycosis although an uncommon infection should be considered due to extensive use of glucocorticoid therapy and concurrent comorbidities present among COVID-19 patients. | |
| dc.identifier | https://doi.org/10.3126/nrj.v1i1.45235 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14572/4482 | |
| dc.language.iso | en_US | |
| dc.publisher | Nepalese Respiratory Society | |
| dc.subject | Pulmonary mucormycosis | |
| dc.subject | Severe acute respiratory illness | |
| dc.subject | Mortality | |
| dc.title | Pulmonary Mucormycosis secondary to Severe Acute Respiratory Illness due to Covid 19 Infection: A Case Report Authors | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| local.article.type | Case Report | |
| oaire.citation.endPage | 18 | |
| oaire.citation.startPage | 15 | |
| relation.isJournalIssueOfPublication | 08a1c199-f08d-4411-9c94-fab2af2925ad | |
| relation.isJournalIssueOfPublication.latestForDiscovery | 08a1c199-f08d-4411-9c94-fab2af2925ad | |
| relation.isJournalOfPublication | 91ea7cc8-46b2-4796-94bd-2998c28b5ebb |